GLOBAL DIAGNOSTICS acquired by MEDICA GROUP
Context
Global Diagnostics Ireland, which operates around 50 clinical centers across Ireland, has been acquired by Medica Group. For Medica, this acquisition represents a diversification of its customer base and geographic activities, as well as entry into a new market: ophthalmology and retinopathy screening.
GLOBAL DIAGNOSTICS, which reported an EBITDA margin of [members only] in 2019, is valued in this transaction at an EV/EBITDA multiple of 10x–18x, representing a discount to the average currently observed in the Healthcare & Pharma sector (14.3x).
-> Deep-dive in Healthcare & Pharma market trends
Target
Global Diagnostics Ireland functions as a high-fidelity diagnostic partnership platform, specializing in the delivery of managed radiology and teleradiology services to both public and private healthcare sectors. The organization operates a sophisticated technical infrastructure that encompasses plain film, ultrasound, CT, and MRI managed-service solutions across dozens of clinical sites. Rather than offering generic diagnostic support, the firm utilizes its specialized technical operational depth to manage high-stakes national screening initiatives, particularly for diabetic retinopathy. Its strategy is anchored in being an embedded clinical partner for the Irish Health Service Executive (HSE), utilizing a network of certified specialist radiologists to mitigate the systemic undersupply of regional diagnostic talent. The entity facilitates the transition of complex clinical imaging into a streamlined, tech-enabled reporting workflow, ensuring that critical diagnostic data is accessible and actionable for hospital teams.
Ent. Value
€10–30M
Equity Value
[members only]
Multiples
EV / Revenue
1x–3x
EV / EBITDA
10x–18x
EV / EBIT
[members only]
Historical Financials (EUR)
Similar deals in Health Providers
Similar deals in Health Providers
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 12/2020 | MEDIAN KLINIKEN | PRIORY GROUP | UNITED KINGDOM | Clinics / Hospitals |
| 12/2020 | FRESENIUS | EUGIN GROUP | SPAIN | Outpatient Care |
| 11/2020 | DWS GROUP | MEDIPASS | ITALY | Radiology |
| 11/2020 | ARDIAN | INOVIE GROUP | FRANCE | Labs (Biology) |
| 11/2020 | APHEON (EX ERGON) | VIDACURA | GERMANY | Nursing Homes |
| 11/2020 | L CATTERTON | ALLIANCE ANIMAL HEALTH | UNITED STATES | Vet Clinics |
| 10/2020 | INFRATIL | QSCAN GROUP | AUSTRALIA | Radiology |
| 10/2020 | THE VISTRIA GROUP / CENTERBRIDGE PARTNERS | HELP AT HOME | UNITED STATES | Nursing Homes |
| 10/2020 | KKR / TETHYS INVEST / ARDIAN / CNP ASSURANCES / MERIEUX EQUITY PARTNERS | ELSAN | FRANCE | Clinics / Hospitals |
| 09/2020 | EQT PARTNERS | COLISÉE | FRANCE | Nursing Homes |
REFERENCES
Valuation range: EV €10–30M
Revenue range: €5–25M
EBITDA range: €0–5M
EV/Revenue range: 1x - 3x
EV/EBITDA range: 10x - 18x
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of GLOBAL DIAGNOSTICS by MEDICA GROUP are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Press release: view release
Acquirer: medica group